Choose language:
		Keyword:
About us Products Business Development Manufacturing Investor Relations Announcements 2009 2008 2007 2006 2005 2004 2003 Annual Report 2008 Annual General Meeting 2009 Share information Shareholder Portal Event Calendar Annual & Interim Reports Key Figures Webcast Presentations Analysts IR Policy Articles of Association Guidelines for Incentive Pay Corporate Governance Contact Press Join Us		Announcements for the Copenhagen Stock Exchange in 2008 16 December 2008 (No. 27-08) Bavarian Nordic upgrades the financial guidance for 2008 10 December 2008 (No. 26-08) Bavarian Nordic A/S issues Financial Calendar for 2009 1 December 2008 (No. 25-08) The Government of Canada procures IMVAMUNE® smallpox vaccine for the country’s biological preparedness 19 November 2008 (No. 24-08) Bavarian Nordic A/S – Major Shareholder Announcement 19 November 2008 (No. 23-08) Bavarian Nordic receives USD 25 million milestone payment after submission of important IMVAMUNE® data to the U.S. Health Authorities 5 November 2008 (No. 22-08) Bavarian Nordic reports successful safety data from Phase II study with IMVAMUNE® 4 November 2008 (No. 21-08) Bavarian Nordic A/S – Interim Report for the period 1 January to 30 September 2008 17 October 2008 (No. 20-08) Bavarian Nordic awards warrants to management and certain employees and introduces incentive programme for all employees 7 October 2008 (No. 19-08) Bavarian Nordic announces positive mature Phase II results from newly acquired prostate cancer vaccine 19 August 2008 (No. 18-08) Bavarian Nordic A/S – Interim Report for the period 1 January to 30 June 2008 13 August 2008 (No. 17-08) Bavarian Nordic announces partnership with National Cancer Institute in the US and obtains rights to a new vaccine candidate 30 June 2008 (No. 16-08) Bavarian Nordic files patent infringement suit against Oxford BioMedica 19 June 2008 (No. 15-08) Bavarian Nordic reports interim data from Phase I/II studies with breast cancer vaccine 3 June 2008 (No. 14-08) Bavarian Nordic enters clinical trials with prostate cancer vaccine 27 May 2008 (No. 13-08) Bavarian Nordic enters clinical trials with HIV multiantigen vaccine 26 May 2008 (No. 12-08) Bavarian Nordic A/S – Report on the Results of the Extraordinary General Meeting, held 26 May 2008 21 May 2008 (No. 11-08) Bavarian Nordic A/S – Extraordinary General Meeting, proxies 8 May 2008 (No. 10-08) Bavarian Nordic A/S – Notice convening extraordinary general meeting 30 April 2008 (No. 09-08) Bavarian Nordic A/S – Major Shareholder Announcement 29 April 2008 (No. 08-08) Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held 29 April 2008 29 April 2008 (No. 07-08) Bavarian Nordic A/S – Interim Report for the period 1 January to 31 March 2008 24 April 2008 (No. 06-08) Bavarian Nordic A/S – Annual General Meeting, proxies 14 April 2008 (No. 05-08) Bavarian Nordic A/S propose changes in Board of Directors 8 April 2008 (No. 04-08) Bavarian Nordic A/S – Board of Directors’ comments to proposed resolutions from shareholder to be considered at the Annual General Meeting 8 April 2008 (No. 03-08) Bavarian Nordic A/S – Notice convening ordinary general meeting 31 March 2008 (No. 02-08) Bavarian Nordic A/S – Annual Results 2007 25 January 2008 (No. 01-08) Bavarian Nordic A/S announces change in management
Home | Sitemap | Disclaimer/Privacy Contact us